Insulin-like growth factor binding protein-3 (IGFBP-3) exerts varying effects on estrogen receptor alpha (ERα)-positive and triple-negative breast cancer (TNBC) cells. This evidence concerns the gene IGFBP3 and triple-negative breast carcinoma.